Condition: ALS (Amyotrophic Lateral Sclerosis) · Sponsor: Chulalongkorn University
Interested? Contact the study team ↓
This is a prospective, observational, multicenter registry designed to collect comprehensive clinical, genetic, and outcome data from patients diagnosed with amyotrophic lateral sclerosis (ALS) across Thailand. The registry will establish a national dataset to describe epidemiology, clinical presentation, progression, and treatment outcomes, and will serve as a platform for future clinical and translational research.
This description comes directly from the study's public registry record.
Jakkrit Amornvit, MD · +66622169338 · jakkrit.a@chula.ac.th
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Diagnosis of ALS according to El Escorial or Gold Coast criteria * Age ≥ 18 years * Ability and willingness to provide informed consent Exclusion Criteria: * Patients unwilling to provide informed consent * Patients with alternative diagnoses mimicking ALS
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| King Chulalongkorn Memorial hospital, The Thai Red Cross Society | Pathum Wan, Bangkok, Thailand | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.